Education
About Us
Working with TipRanks
Follow Us
Evolent Health Inc. (EVH)
:EVH
EVH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$8.35 - $33.63
Previous CloseN/A
Volume268.11K
Average Volume (3M)2.36M
Market Cap
$1.05B
Enterprise Value$2.03B
Total Cash (Recent Filing)-$67.89M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.09
Next Earnings
May 08, 2025EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.81
Shares Outstanding116,591,150
10 Day Avg. Volume2,366,848
30 Day Avg. Volume2,355,064
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.44
Price to Cash Flow (P/CF)-10.70
P/FCF Ratio0.00
Enterprise Value/Market Cap1.94
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.54
Enterprise Value/Ebitda24.43
Forecast
1Y Price Target
$15.80Price Target Upside75.95% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
---
Evolent Health News
PremiumCompany Announcements
Evolent Health Nominates Shawn Guertin to Board
PremiumCompany Announcements
Evolent Health Inc. Reports Mixed Earnings Results---
Bulls Say, Bears Say
Bulls Say
Contract WinsEvolent Health has signed a Technology and Services contract expansion with a large New England health plan, indicating strong sales momentum and demand.
Customer LoyaltyEvolent Health reported 100% logo retention for its top customers, which contribute to 90% of its consolidated revenue, highlighting strong customer loyalty.
Growth OpportunitiesEvolent Health represents an attractive buying opportunity, particularly given its ability to drive over 20% growth, beginning in 2026.
Bears Say
Market PerceptionInvestors are likely to view the FY25 outlook negatively due to Q4 events.
Oncology CostsElevated cancer costs continued to negatively impact profitability.
Revenue GuidanceEvolent Health's 2025 revenue and adjusted EBITDA guidance are below previous estimates and consensus expectations.
---
Ownership Overview
2.07% Insiders
33.24% Mutual Funds
0.44% Other Institutional Investors
48.79% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EVH FAQ
What was Evolent Health Inc.’s price range in the past 12 months?
Evolent Health Inc. lowest stock price was $8.35 and its highest was $33.63 in the past 12 months.
What is Evolent Health Inc.’s market cap?
Evolent Health Inc.’s market cap is $1.05B.
When is Evolent Health Inc.’s upcoming earnings report date?
Evolent Health Inc.’s upcoming earnings report date is May 08, 2025 which is in 11 days.
How were Evolent Health Inc.’s earnings last quarter?
Evolent Health Inc. released its earnings results on Feb 20, 2025. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of $0.03 by -$0.05.
Is Evolent Health Inc. overvalued?
According to Wall Street analysts Evolent Health Inc.’s price is currently Undervalued.
Does Evolent Health Inc. pay dividends?
Evolent Health Inc. does not currently pay dividends.
What is Evolent Health Inc.’s EPS estimate?
Evolent Health Inc.’s EPS estimate is 0.09.
How many shares outstanding does Evolent Health Inc. have?
Evolent Health Inc. has 116,591,150 shares outstanding.
What happened to Evolent Health Inc.’s price movement after its last earnings report?
Evolent Health Inc. reported an EPS of -$0.02 in its last earnings report, missing expectations of $0.03. Following the earnings report the stock price went down -2.614%.
Which hedge fund is a major shareholder of Evolent Health Inc.?
Currently, no hedge funds are holding shares in EVH
---
Evolent Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$15.80 (75.95% Upside)
$15.80 (75.95% Upside)
Blogger Sentiment
Bullish
EVH Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 3.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.1%
Last 30 Days ▼ 5.6%
Last 30 Days ▼ 5.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-68.29%
12-Months-Change
Fundamentals
Return on Equity
-5.96%
Trailing 12-Months
Asset Growth
-5.07%
Trailing 12-Months
Company Description
Evolent Health Inc.
Evolent Health (EVH) is a healthcare company that provides technology-driven solutions to healthcare providers and payers. The company focuses on helping health systems and physician organizations transition to value-based care, where the emphasis is on optimizing health outcomes and reducing costs. Evolent Health's core offerings include clinical and administrative solutions, performance improvement services, and a proprietary platform designed to enhance clinical and financial performance.
---
EVH Company Deck
---
EVH Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Evolent demonstrated strong revenue growth and successful contract renewals, but faced challenges with oncology expenses and Medicaid headwinds. The company is investing in efficiency improvements and has renegotiated contracts to improve EBITDA, yet projects a cautious outlook for 2025.Read More>---
EVH Stock 12 Month Forecast
Average Price Target
$15.80
▲(75.95% Upside)
Technical Analysis
Best Analysts Covering EVH
1 Year
1 Year Success Rate
20/46 ratings generated profit
1 Year Average Return
+11.39%
reiterated a buy rating 2 months ago
Copying Richard Close's trades and holding each position for 1 Year would result in 43.48% of your transactions generating a profit, with an average return of +11.39% per trade.
---